Citadel Advisors’s First Trust Emerging Markets Human Flourishing ETF FTHF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$972K Sell
19,534
-106,711
-85% -$4.88M ﹤0.01% 8263
2026
Q1
$4.72M Buy
+126,245
New +$4.8M ﹤0.01% 4443
2025
Q1
Sell
-36,415
Closed -$764K 14852
2024
Q4
$764K Buy
36,415
+15,132
+71% +$343K ﹤0.01% 7601
2024
Q3
$503K Buy
21,283
+359
+2% +$8.55K ﹤0.01% 8245
2024
Q2
$489K Buy
20,924
+47
+0.2% +$1.11K ﹤0.01% 8093
2024
Q1
$499K Buy
+20,877
New +$481K ﹤0.01% 8406

Other funds holding FTHF

Citadel Advisors's FTHF Position: Q2 2026 in Review

Citadel Advisors reduced its First Trust Emerging Markets Human Flourishing ETF (FTHF) stake by 85% in Q2 2026, selling an estimated $4.88M and leaving 19,534 shares worth $972K. The position accounts for ﹤0.01% of the portfolio, ranked #8263.

Citadel Advisors first reported a position in FTHF in Q1 2024 and has held it in 6 quarters since. The position peaked at $4.72M in Q1 2026. 29 funds tracked by Wall St. Rank hold FTHF as of Q2 2026.

  • Citadel Advisors held 19,534 shares of First Trust Emerging Markets Human Flourishing ETF worth $972K as of Q2 2026.
  • Citadel Advisors sold 106,711 First Trust Emerging Markets Human Flourishing ETF shares in Q2 2026, an estimated $4.88M.
  • First Trust Emerging Markets Human Flourishing ETF made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #8263 holding.
  • Citadel Advisors first reported a position in First Trust Emerging Markets Human Flourishing ETF in Q1 2024 and has held it in 6 quarters since.
  • Citadel Advisors's First Trust Emerging Markets Human Flourishing ETF position peaked at $4.72M in Q1 2026.
  • 29 funds tracked by Wall St. Rank held First Trust Emerging Markets Human Flourishing ETF as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.